Related Experiment Video
Updated: Jun 16, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis
Tahera Zabuawala1, David A Taffany, Sudarshana M Sharma
1Department of Molecular and Cellular Biochemistry, Center for Biostatistics, College of Public Health, and Tumor Microenvironment Program, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210, USA.
Abstract:
Tumor-associated macrophages (TAM) are implicated in breast cancer metastasis, but relatively little is known about the underlying genes and pathways that are involved. The transcription factor Ets2 is a direct target of signaling pathways involved in regulating macrophage functions during inflammation. We conditionally deleted Ets in TAMs to determine its function at this level on mouse mammary tumor growth and metastasis. Ets2 deletion in TAMs decreased the frequency and size of lung metastases in three different mouse models of breast cancer metastasis. Expression profiling and chromatin immunoprecipitation assays in isolated TAMs established that Ets2 repressed a gene program that included several well-characterized inhibitors of angiogenesis. Consistent with these results, Ets2 ablation in TAMs led to decreased angiogenesis and decreased growth of tumors. An Ets2-TAM expression signature consisting of 133 genes was identified within human breast cancer expression data which could retrospectively predict overall survival of patients with breast cancer in two independent data sets. In summary, we identified Ets2 as a central driver of a transcriptional program in TAMs that acts to promote lung metastasis of breast tumors.
Insights
Transcription factor Ets2 in tumor-associated macrophages (TAMs) drives breast cancer metastasis by repressing anti-angiogenic genes. Inhibiting Ets2 in TAMs reduced tumor growth and spread, offering a potential therapeutic target.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tumor-associated macrophages (TAMs) play a critical role in breast cancer metastasis.
- The specific genes and pathways regulated by TAMs in metastasis are not fully understood.
- Ets2 is a transcription factor involved in macrophage function and inflammation.
Purpose of the Study:
- To investigate the role of Ets2 in TAMs during breast cancer growth and metastasis.
- To identify the downstream targets and mechanisms by which Ets2 influences metastasis.
Main Methods:
- Conditional deletion of Ets2 in TAMs in mouse models of breast cancer.
- Gene expression profiling and chromatin immunoprecipitation assays on isolated TAMs.
- Analysis of angiogenesis, tumor growth, and lung metastasis.
- Identification and validation of an Ets2-TAM expression signature in human breast cancer data.
Main Results:
- Ets2 deletion in TAMs significantly reduced lung metastasis frequency and size in multiple mouse models.
- Ets2 was found to repress a gene program including angiogenesis inhibitors.
- Ablation of Ets2 in TAMs led to decreased angiogenesis and tumor growth.
- An Ets2-TAM signature of 133 genes predicted patient survival in human breast cancer datasets.
Conclusions:
- Ets2 is a key driver of a transcriptional program in TAMs that promotes breast cancer lung metastasis.
- Ets2 regulates angiogenesis and tumor growth through its effects on TAMs.
- The identified Ets2-TAM signature serves as a potential biomarker for breast cancer prognosis.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
